Effect of Angiotensin II on Striatal Dopamine Release in the Spontaneous Hypertensive Rat

References

• Allen A M., Paxinos G., McKinley M. J., Chai S. Y., Mendelsohn F. A.O. Localization and characterization of angioteasin II receptor binding sites in the human basal ganglia, thalamus, midbrain, pons and cerebellum. J Comp Neurol. 1991; 312: 291–298
   PubMed Web of Science ®Google Scholar
• MacGregor D P., Murone C., Song K., Allen A. M., Paxinos G., Mendelsohn F. A.O. Angiotensin II receptor subtypes in the human central nervous system. Brain Res. 1995; 675: 231–240
   PubMed Web of Science ®Google Scholar
• Allen A M., MacGregor D. P., Chai S. Y., Donnan G. A., Kaczmarczyk S. J., Richardson K., Kalnins R. M., Ireton J., Mendelsohn F. A.O. Angiotensin II receptor binding associated with nigro-striatal dopaminergic neurones in human basal ganglia. Ann Neurol. 1992; 32: 339–344
   PubMed Web of Science ®Google Scholar
• Ge J, Barnes N. M. Alterations in angiotensin AT1 and AT2 receptor subtype levels in brain regions from patients with neurodegenerative disorders. Eur J Pharmacol. 1996; 297: 299–306
   PubMed Web of Science ®Google Scholar
• Simonnet G, Giorguieff-Chesselet M. F. Stimulating effect of angiotensin II on the spontaneous release of newly synthesized [3H] dopamine in rat striatal slices. Neurosci Lett. 1979; 15: 153–158
   PubMed Web of Science ®Google Scholar
• Dwoskin L P., Jewell A. L., Cassis L. A. DuP 753 a nonpeptide angiotensin II-1 receptor antagonist, alters dopaminergic function in the rat striatum. Naunyn Schmiedeberg's Arch Pharmacol. 1992; 345: 153–159
   Google Scholar
• Brown D C., Steward L. J., Ge J., Barnes N. M. Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo. Br J Pharmacol. 1996; 118: 414–420
   PubMed Web of Science ®Google Scholar
• Mendelsohn F A.O., Jenkins T. A., Berkovic S. F. Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats. Brain Res. 1993; 613: 221–229
   PubMed Web of Science ®Google Scholar
• Jenkins T A., Chai S. Y., Howells D. W., Mendelsohn F. A.O. Effects of dopamine agonists and antagonists on angiotensin-II stimulated dopamine release in the rat striatum. Brain Res. 1996, (submitted).
   PubMedGoogle Scholar
• Braszko J J., Kupryszewski G., Witczuk B., Wisniewski K. Angiotensin II, some of its fragments and saralasin affect dopamine in the striatum but not in the olfactory tubercle. Pharmacological Research 1992; 25(suppl 2)9–10
   PubMedGoogle Scholar
• Jenkins T A., Chai S. Y., Howells D. W., Mendelsohn F. A.O. Intrastriatal angiotensin II induces turning in 6-hydroxy dopamine lesioned rats. Brain Res. 1995; 691: 213–216
   PubMed Web of Science ®Google Scholar
• Qadri F, Badoer E., Stadler T., Veltmar A., Unger T. Interaction of angiotensin II with catecholamines in the brain. Central neural mechanisms in cardiovascular regulation, G Kunos, J. Ciriello. Birkhauser, Boston 1991; 85–94
   Google Scholar
• Jenkins T A., Allen A. M., Chai S. Y., Mendelsohn F. A.O. Interactions of angiotensin II with central catecholamines. Clin Exp Hypertens. 1995; 17: 267–280
   PubMed Web of Science ®Google Scholar
• Fitzsimons J T., Setler P. E. The relative importance of central nervous catecholaminergic and cholinergic mechanisms in drinking in response to angiotensin and other thirst stimuli. J Physiol. 1975; 250: 613–631
   PubMed Web of Science ®Google Scholar
• Simmers C, Woodruff G. N., Poat J. A., Munday K. A. The effect of neuroleptic drugs on drinking induced by central administration of angiotensin or carbachol. Psychopharmacology 1979; 60: 291–294
   PubMed Web of Science ®Google Scholar
• Kawabe H, Brosnihan B., Diz D. I., Ferrario C. M. Role of brain dopamine in centrally evoked angiotensin II responses in conscious rats. Inter-Am Soc Proc. 1986; 8(4)184–189
   Google Scholar
• Hoffman W E., Phillips M. I., Schmid P. The role of catecholamines in central antidiuretic and pressor mechanisms. Neuropharmacology 1977; 16: 563–569
   PubMed Web of Science ®Google Scholar
• Gordon F J., Brody M. J., Fink G. D., Buggy J., Johnson A. K. Role of central catecholamines in the control of blood pressure and drinking behaviour. Brain Res. 1979; 178: 161–173
   PubMed Web of Science ®Google Scholar
• Bellin S I., Landas S. K., Johnson A. K. Localized injection of 6-hydroxydopamine into lamina terminalis-associated structures: effect on experimentally induced drinking and pressor responses. Brain Res. 1987; 416: 75–83
   PubMed Web of Science ®Google Scholar
• Pirola C J., Scheucher A., Balda M. S., Dabsys S. M., Finkielman S., Nahmod V. E. Serotonin modulates cardiovascular responses to acetylcholine, bradykinin, angiotensin II and norepinephrine in the lateral septal area of the rat brain. Neuropharmacology 1987; 26(6)561–566
   PubMed Web of Science ®Google Scholar
• Walters D E., Speth R. C. Monoamine depletion does not alter angiotensin II binding sites in the rat brain. Brain Res Bull. 1989; 22: 283–288
   PubMed Web of Science ®Google Scholar
• Tobia A J, Walsh G. M. The spontaneous hypertensive rat. Hypertension research. Methods and models, F M Radzialowski. Marcel Dekker, Inc., New York 1983; 427–446
   Google Scholar
• Yamori Y. Development of the spontaneous hypertensive rat (SHR) and of various spontaneous rat models, and their implications. Experimental and genetic models of hypertension, W De Jong. Elsevier Science Publishers. 1984; 224–239
   Google Scholar
• Phillips M I., Kimura B. K. Levels of brain angiotensin in the spontaneous hypertensive rat and treatment with ramiprilat. J Hypertens. 1986; 4: S391–S394
   Google Scholar
• Weyhenmeyer J. A., Phillips M. I. Angiotensin-like immunoreactivity in the brain of the spontaneously hypertensive rat. Hypertens. 1982; 4: 514–523
   PubMed Web of Science ®Google Scholar
• Hoffman W E., Phillips M. I., Schmid P. Central angiotensin II-induced responses in spontaneous hypertensive rats. Am J Physiol. 1977; 232: H426–H433
   PubMed Web of Science ®Google Scholar
• Van Den Buuse M., De Jong W. Pharmacology of central dopaminergic modulation in hypertension. Progress in Hypertension — Antihypertensive drugs today, H Saito. VSP NE Coronet Books. 1992; 157–188
   Google Scholar
• Raizada M K., Muther T. F., Sumners C. Increased angiotensin II receptors in neuronal cultures from hypertensive rat brain. Am J Physiol. 1984; 247: C364–372
   PubMed Web of Science ®Google Scholar
• Gehlert D R., Speth R. C., Walmsley J. K. Quantitative autoradiography of angiotensin II receptors in the SHR brain. Peptides 1986; 7: 1021–1027
   PubMed Web of Science ®Google Scholar
• Kujiral K, Przedborski S., Kostic V., Jackson-Lewis V., Fahn S., Cadet J. L. Autoradiography of dopamine receptors and dopamine uptake sites in the spontaneous hypertensive rat. Brain Res Bull. 1990; 25: 703–709
   PubMed Web of Science ®Google Scholar
• Verberne A J.M., Widdop R. E., Maccarrone C., Jarrott B., Beart P. M., Louis W. J. Intrathecal kynurenate reduces arterial pressure, heart rate and baroreceptor — heart rate reflex in conscious rats. Neurosci Lett. 1990; 114: 309–315
   PubMed Web of Science ®Google Scholar
• Paxinos G, Watson C. The Rat Brain in stereotaxic coordinates. Academic Press, Sydney 1982
   Google Scholar
• Meyer J M., Felten D. L., Weyhenmeyer J. A. Levels of immunoreactive angiotensin II in microdissected nuclei from adult WKY and SHR rat brain. Clin Exp Hypertens. 1989; A11: 103–117
   Google Scholar
• Van Den Buuse M., Versteeg D. H.G., De Jong W. Brain dopamine depletion by lesions in the substantia nigra attenuates the development of hypertension in the spontaneous hypertensive rat. Brain Res. 1986; 368: 69–78
   PubMed Web of Science ®Google Scholar
• Nagaoka A, Lovenberg W. O. Regional changes in the activities of aminergic biosynthetic enzymes in the brains of hypertensive rats. Eur J Pharmacol. 1977; 43: 297–306
   PubMed Web of Science ®Google Scholar
• Ikeda M, Hirata Y., Fujita K., Shinzato M., Takahashi Y., Yagyu S., Nagatsu T. Effects of stress on release of dopamine and serotonin in the striatum of spontaneously hypertensive rats: an in vivo voltametric study. Neurochem Int. 1985; 6: 509–512
   Web of Science ®Google Scholar
• Fuller R W., Hemrick-Luecke S. K., Wong D. T., Pearson D., Threllkeld P. G., Hynes M. Altered behavioural response to a D2 agonist, LY141865, in SHR exhibiting biochemical and endocrine responses similar to those in normotensive rats. J Pharmacol Exp Ther. 1983; 227: 354–359
   PubMed Web of Science ®Google Scholar
• Van Den Buuse M., Linthorst A. C.E., Versteeg D. H.G., De Jong W. Role of brain dopamine systems in the development of hypertension in the spontaneous hypertensive rat. Clin Exp Hypertens. 1991; 13: 653–659
   Web of Science ®Google Scholar
• Linthorst A C.E., Van Den Buuse M., De Jong W., Versteeg D. H.G. Electrically stimulated [3H]dopamine and [14C]acetylcholine release from nucleus caudatus slices: differences between spontaneous hypertensive rats and Wistar-Kyoto rats. Brain Res. 1990; 509: 266–272
   PubMed Web of Science ®Google Scholar
• Linthorst A C.E., De Lang H., De Jong W., Versteeg D. H.G. Effect of dopamine D2 receptor agonist quinpirole on the in vivo release of dopamine in the caudate nucleus of hypertensive rats. Eur J Pharmacol. 1991; 201: 125–133
   PubMed Web of Science ®Google Scholar